• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星联合阿洛西林在中性粒细胞减少部位模型中对12株链球菌分离株的体内和体外活性

In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.

作者信息

Peterson L R, Moody J A, Fasching C E, Gerding D N

机构信息

Medical Service, Veterans Administration Medical Center, Minneapolis, Minnesota 55417.

出版信息

Diagn Microbiol Infect Dis. 1987 Jun;7(2):127-36. doi: 10.1016/0732-8893(87)90030-7.

DOI:10.1016/0732-8893(87)90030-7
PMID:3115671
Abstract

Closed-space neutropenic infection sites were simulated in rabbits by subcutaneous semipermeable chambers that were inoculated with 5 X 10(4) CFU/ml of various strains of Streptococcus pneumoniae, Streptococcus faecalis, and Streptococcus avium. Four hours after inoculation, treatment was begun with ciprofloxacin, 10 or 30 mg/kg, azlocillin, 100 mg/kg, amikacin, 15 mg/kg, procaine penicillin G, 300 U/dose, or gentamicin, 2 mg/kg, alone and in two-drug combinations. Antimicrobials were given intramuscularly every 6 hr for 16 doses. Extravascular chambers were sampled throughout the treatment course for bacterial counts and antimicrobial concentration. In vivo results were compared to in vitro tests of inhibition, killing, and synergism. Ciprofloxacin alone had little effect on the animal infection sites. Azlocillin alone reduced, in vivo, eight of 12 isolates greater than or equal to 5 log10 CFU/ml by 92 hr as compared to control. Azlocillin plus ciprofloxacin reduced all 12 isolates greater than or equal to 5 log10 CFU/ml by 92 hr, whereas amikacin plus azlocillin reduced only three and penicillin plus gentamicin only one of the six group D streptococcal isolates greater than or equal to 5 log10 CFU/ml.

摘要

通过皮下半透室在兔子身上模拟封闭空间中性粒细胞减少的感染部位,向这些半透室接种每毫升含5×10⁴ 菌落形成单位(CFU)的各种肺炎链球菌、粪肠球菌和鸟肠球菌菌株。接种后4小时,开始用环丙沙星(10或30毫克/千克)、阿洛西林(100毫克/千克)、阿米卡星(15毫克/千克)、普鲁卡因青霉素G(300单位/剂量)或庆大霉素(2毫克/千克)进行治疗,单独用药或两药联合使用。抗菌药物每6小时肌肉注射一次,共注射16剂。在整个治疗过程中对血管外腔室进行采样,以进行细菌计数和抗菌药物浓度检测。将体内结果与体外抑制、杀菌和协同作用试验结果进行比较。单独使用环丙沙星对动物感染部位几乎没有影响。与对照组相比,单独使用阿洛西林在92小时内使12株大于或等于5 log₁₀ CFU/ml的分离株中的8株在体内减少。阿洛西林加环丙沙星在92小时内使所有12株大于或等于5 log₁₀ CFU/ml的分离株减少,而阿米卡星加阿洛西林仅使6株大于或等于5 log₁₀ CFU/ml的D组链球菌分离株中的3株减少,青霉素加庆大霉素仅使其中1株减少。

相似文献

1
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.环丙沙星联合阿洛西林在中性粒细胞减少部位模型中对12株链球菌分离株的体内和体外活性
Diagn Microbiol Infect Dis. 1987 Jun;7(2):127-36. doi: 10.1016/0732-8893(87)90030-7.
2
Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.通过多种体外方法评估环丙沙星与其他药物的协同作用。
Am J Med. 1987 Apr 27;82(4A):44-54.
3
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.环丙沙星、阿洛西林、头孢唑肟和阿米卡星单独及联合应用于感染腔室模型中对抗革兰氏阴性杆菌的研究
J Antimicrob Chemother. 1986 Jul;18(1):51-63. doi: 10.1093/jac/18.1.51.
4
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.环丙沙星与阿洛西林在体外及中性粒细胞减少小鼠感染模型中的协同作用。
Eur J Clin Microbiol. 1986 Feb;5(1):23-8. doi: 10.1007/BF02013456.
5
In vitro models for the study of combination antibiotic therapy in neutropenic patients.用于研究中性粒细胞减少患者联合抗生素治疗的体外模型。
Am J Med. 1986 Jun 30;80(6B):156-60. doi: 10.1016/0002-9343(86)90494-8.
6
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.在中性粒细胞减少部位兔模型中,阿洛西林、头孢唑肟、头孢西丁和阿米卡星单独及联合应用对铜绿假单胞菌的比较。
Antimicrob Agents Chemother. 1984 May;25(5):545-52. doi: 10.1128/AAC.25.5.545.
7
Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients.环丙沙星与阿洛西林联用对比庆大霉素与阿洛西林联用治疗发热性中性粒细胞减少症患者的随机多中心研究
J Antimicrob Chemother. 1990 Dec;26 Suppl F:89-99. doi: 10.1093/jac/26.suppl_f.89.
8
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.环丙沙星和头孢唑肟诱导的革兰氏阴性杆菌耐药的治疗。
Am J Med. 1987 Apr 27;82(4A):80-6.
9
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.美洛西林、头孢唑肟和阿米卡星单独及联合应用对兔中性粒细胞减少部位六种肠杆菌科细菌的作用
J Antimicrob Chemother. 1985 Jan;15 Suppl A:207-19. doi: 10.1093/jac/15.suppl_a.207.
10
Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
Diagn Microbiol Infect Dis. 1987 Jan;6(1):59-67. doi: 10.1016/0732-8893(87)90115-5.

引用本文的文献

1
Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.采用改良的美国国家临床实验室标准委员会肉汤稀释法可获得高度可重复的杀菌活性测试结果。
J Clin Microbiol. 1999 Jun;37(6):1881-4. doi: 10.1128/JCM.37.6.1881-1884.1999.
2
Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
3
In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.
喹诺酮类药物对耐青霉素-氨基糖苷类协同作用肠球菌的体外活性。
Antimicrob Agents Chemother. 1989 Jan;33(1):71-7. doi: 10.1128/AAC.33.1.71.
4
Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.同时给予阿洛西林对环丙沙星药代动力学处置的影响。
Antimicrob Agents Chemother. 1990 May;34(5):823-6. doi: 10.1128/AAC.34.5.823.
5
Screening and treatment of infections caused by resistant enterococci.耐万古霉素肠球菌感染的筛查与治疗
Antimicrob Agents Chemother. 1991 Feb;35(2):215-9. doi: 10.1128/AAC.35.2.215.
6
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.抗菌剂杀菌效果测试:技术性能与临床相关性
Clin Microbiol Rev. 1992 Oct;5(4):420-32. doi: 10.1128/CMR.5.4.420.